ACTFAST (2): Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration: A Multicenter, Twelve-Week Treatment, Single-Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving Low Density Lipoprotein Cholesterol (LDL-C) Target With Atorvastatin Starting Doses Of 10 mg, 20 mg, 40 mg, And 80 mg.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Atorvastatin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms ACTFAST-2
- Sponsors Pfizer
- 03 Apr 2007 New trial record.